J Korean Assoc Maxillofac Plast Reconstr Surg.  2014 Jan;36(1):25-29.

The Use of Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2) in Treatment for Cysts of the Oral and Maxillofacial Regions

Affiliations
  • 1Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center, Korea. bbp2000@hanmail.net

Abstract

The purpose of this study is to report on five cases treated with bone graft using recombinant human bone morphogenetic protein-2 (rhBMP-2) on jaw defects after cyst enucleation. We performed bone graft with BMP (rhBMP-2+beta-tricalcium phosphate/hydroxyapatite) wrapped with a collagen sponge on jaw defects after cyst enucleation. Postoperative panoramic radiographs were taken periodically. After 1 to 12 months, bone remodeling was observed in the jaw defect area. In our cases, there were few signs or symptoms of recurrence of the cyst during the follow-up period.

Keyword

rhBMP-2; Bone transplantation; Odontogenic cysts

MeSH Terms

Bone Remodeling
Bone Transplantation
Collagen
Follow-Up Studies
Humans*
Jaw
Odontogenic Cysts
Porifera
Recurrence
Transplants
Collagen
Full Text Links
  • JKAMPRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr